This review concluded that intraperitoneal chemotherapy in patients undergoing curative resection for gastric cancer may be beneficial compared with gastrectomy. The authors' conclusions follow from the evidence identified. However, given the limited search and language restrictions applied, some relevant studies might not have been included in the review.
The authors stated that two reviewers independently assessed the outcome data using a pre-designed strategy; no further details were provided. The data appeared to have been extracted in an intention-to-treat format. Survival and mortality data were extracted.
Methods of synthesis
How were the studies combined? A pooled odds ratio (OR), along with 95% confidence interval (CI), was calculated using a fixed-effect model. Publication bias was assessed using Rosenthal's fail-safe N.
How were differences between studies investigated?
The chi-squared test was used to investigate whether statistical heterogeneity was present between the studies included in the meta-analysis. A sensitivity analysis, which explored the effects of excluding trials with a low Jadad score, was also performed. Subgroup analyses were also executed; these investigated the effect of follow-up time (less than 60 months versus more than 60 months), chemotherapy group (IPT without CH and IHCP versus IPT with CH versus IHCP alone) and setting (Asia versus non-Asia).
Results of the review
Eleven RCTs (n=1,161) were included.
Three of the included RCTs were deemed to be of high quality: one trial was double-blind with a sample size calculation and two trials used intention-to-treat analyses. According to the authors, the calculated fail-safe N of 104 indicated that no important publication bias was present.
The pooled analysis showed that there were fewer deaths with IPT than surgery alone (OR 0.51, 95% CI: 0.40, 0.65). No statistically significant heterogeneity was identified and the exclusion of trials with low Jadad scores did not affect the results of the meta-analysis. The subgroup analysis of chemotherapy group suggested that there were fewer deaths with IHCP (7 RCTs) and IPT with CH (2 RCTs) than with IPT (2 RCTs) compared with surgery; the ORs were 0.48 (95% CI: 0.35, 0.67), 0.52 (95% CI: 0.29, 0.94) and 0.57 (95% CI: 0.35, 0.92), respectively. The subgroup analysis of setting suggested that trials based in Asian countries (9 RCTs) had fewer deaths than those from non-Asian countries (2 RCTs), ORs of 0.49 (95% CI: 0.38, 0.64) and 0.67 (95% CI: 0.32, 1.41), respectively. The subgroup analysis of length of follow-up suggested that the benefit of IPT compared with surgery was more significant in trials with a follow-up of less than 60 months (6 RCTs) than in those with a follow-up of more than 60 months (5 RCTs), ORs 0.40 (95% CI: 0.27, 0.59) and 0.60 (95% CI: 0.44, 0.82), respectively.
Five of the 11 included RCTs reported mild complications, three reported no significant differences between the IPT group and surgery group, and two reported complications in the chemotherapy group. One RCT, which was conducted in Austria, was terminated early due to serious adverse events and death in the chemotherapy group.
Authors' conclusions
IPT after curative resection for locally advanced gastric cancer may be beneficial to patients.
CRD commentary
The review question was relatively clear in terms of the interventions, study designs and participants eligible for inclusion in the review. Some relevant sources were searched. However, unpublished literature was not sought and language restrictions were applied, which could lead to language bias; there was no evidence of publication bias according to the fail-safe N calculated. It appears that appropriate methods might have been employed in determining the eligibility of studies, assessing their quality, and extracting the data, which reduces the possibility of reviewer bias and error. Established criteria were used to assess the quality of the included studies. These suggested that the included studies were generally of poor quality, although sensitivity analyses suggested that the lower quality studies were not affecting the results of the meta-analysis.
